Using advanced MRI techniques to improve management of renal cancer and kidney function
Official title: Advanced Diffusion Imaging for Management of Renal Cancer: Oncologic Control and Renal Functional Reserve - Resubmission - 1
Funded at New York University School of Medicine · NIH-11078806 · Data updated 2026-11-12
This study is looking at new MRI techniques to help doctors understand how kidney cancer affects kidney function and to see how surgery might help, so patients can get better care before and after their treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 1, 2020 |
| Project end | April 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $534,967 |
| NIH project number | 5R01CA245671-06 |
| Project ID | NIH-11078806 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with renal cancer who are scheduled for surgical intervention.
✕Less likely to help
Patients with renal cancer who are not candidates for surgery or those with advanced kidney disease may not benefit from this research.
What this research studies
This research focuses on developing advanced diffusion-weighted MRI techniques to monitor renal function in patients with renal cancer. It aims to noninvasively assess the aggressiveness of tumors and predict the impact of surgical interventions on kidney function. By utilizing innovative imaging methods, the study seeks to provide better insights into the health of the kidneys before and after surgery, potentially improving patient outcomes. Patients will undergo MRI scans to evaluate their condition and track changes over time.
Why it matters
Potential benefit: If successful, this research could lead to improved management strategies for renal cancer patients, helping to preserve kidney function and reduce the risk of chronic kidney disease.
How similar studies have gone: Previous research has shown promise in using advanced MRI techniques for cancer assessment, indicating potential success for this novel approach.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Sigmund, Eric Edward — New York University School of Medicine
- Study coordinator: Sigmund, Eric Edward
Related research
Other NIH-funded projects on the same topics.
-
Profilin as a Target to Normalize Tumor Vessels in Kidney Cancer
A new approach aims to curb blood vessel growth in a common kidney cancer by targeting a protein called Profilin 1 to improve how blood vessels form in tumors.
-
Overcoming obesity-related resistance to immunotherapy in kidney cancer
A study aims to understand why obesity affects how well immunotherapy works for people with advanced kidney cancer and how to improve treatments for those patients.
-
Copper-driven metabolism in clear cell kidney cancer relapse
This grant studies how copper metabolism affects the growth and relapse of clear cell renal cell carcinoma to identify new ways to help patients after surgery.
-
New VHL tumor-suppressor signaling in kidney cancer
This project looks at why a common kidney cancer (ccRCC) resists treatment and how changes in a gene called VHL and a chemical tag on RNA might open new ways to fight it.
-
Targeting epigenetic drivers in clear cell kidney cancer
A doctor-scientist at Johns Hopkins is exploring how epigenetic changes shape kidney cancer and whether new therapies can target these changes.
-
Targeting profilin to normalize blood vessels in kidney cancer
This work tests whether blocking a protein called profilin can normalize tumor blood vessels and help people with clear cell kidney cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.